The Dispatch
Share this post
Was Trump’s Antibody Cocktail Created Through Research Using Embryonic Stem Cells?
thedispatch.com

Was Trump’s Antibody Cocktail Created Through Research Using Embryonic Stem Cells?

No.

Alec Dent
Oct 7, 2020
27
16
Share this post
Was Trump’s Antibody Cocktail Created Through Research Using Embryonic Stem Cells?
thedispatch.com

Update, October 8: Further coverage of REGN-COV2 by the MIT Technology Review and the New York Times revealed that the drug cocktail was developed with cells derived from a cell line called 293T, which was derived from kidney tissue taken from an abortion in the 1970s. This information provides important further information about REGN-COV2, but does not contradict the original findings of the fact check below: Cells derived from the surface of organs, as is the case with the 293T cells, are epithelial cells, not stem cells, and no embryonic stem cells were used in Regeneron’s development of REGN-COV2. Regardless, the technical distinction between the cells does not detract from the fact that both are considered morally objectionable by many in the pro-life movement and the Trump administration has voiced opposition to such research on pro-life grounds. In 2019, the Trump administration suspended federal funding of research involving fetal tissue obtained from abortions. 

Following President Trump’s treatment for coronavirus at Walter Reed National Military Medical Center, claims started to go viral that an experimental drug cocktail called REGN-COV2 he received was created through research that involved human embryonic stem cells.

Twitter avatar for @tedlieuTed Lieu @tedlieu
Regeneron, an experimental drug which @POTUS took, relied on “human embryonic stem cells.” I support this research. I wonder if @realDonaldTrump and Amy Coney Barrett support this research?
Image

October 6th 2020

25,404 Retweets62,882 Likes

The basis for these claims was an April 2020 statement from the company behind the drug, Regeneron, which states that Regeneron “uses a wide variety of research tools and technologies to help discover and develop new therapeutics. Stem cells are one such tool.” The statement goes on to mention that “there are limited research efforts employing human-induced pluripotent stem cell lines derived from adult human cells and human embryonic stem cells that are approved for research use by the National Institutes of Health and created solely through in vitro fertilization.”

The statement, however, refers to research done by Regeneron in general, not what research was performed with the drug cocktail Trump received specifically. There is no evidence publicly available to support the claim that REGN-COV2 utilized embryonic stem cells. What’s more, a Regeneron representative told The Dispatch Fact Check that “Regeneron’s REGN-COV2 program did not involve use of human stem cells, embryonic stem cells or fetal tissue.”

If you have a claim you would like to see us fact check, please send us an email at factcheck@thedispatch.com. If you would like to suggest a correction to this piece or any other Dispatch article, please email corrections@thedispatch.com.

Photograph by Win McNamee/Getty Images.

16
Share this post
Was Trump’s Antibody Cocktail Created Through Research Using Embryonic Stem Cells?
thedispatch.com
16 Comments

Create your profile

0 subscriptions will be displayed on your profile (edit)

Skip for now

Only Dispatch Members only can comment on this post

Already a paid subscriber? Sign in

Check your email

For your security, we need to re-authenticate you.

Click the link we sent to , or click here to sign in.

Matmos
Oct 9, 2020Liked by Alec Dent

Thanks for the update/clarification!

Expand full comment
ReplyCollapse
1 reply
DougAz
Oct 9, 2020

This from Regeneron (duh..the name!!) Does not sound fully truthful to me:

"What’s more, a Regeneron representative told The Dispatch Fact Check that “Regeneron’s REGN-COV2 program did not involve use of human stem cells, embryonic stem cells or fetal tissue.”

Expand full comment
ReplyCollapse
14 more comments…
TopNewCommunity

No posts

Ready for more?

© 2022 The Dispatch
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing